Michael Scolaro

Michael Scolaro

Sep 08, 2017

Group 6 Copy 167
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Can we noninvasively measure blood sugar for diabetes?

Better management of type 1 diabetes is moving towards anartificial pancreas. However, we need a better way...

Can albumin from egg whites be used to treat Clostridium difficile infections?

Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections and...

Are coyotes contributing to the spread Rocky Mountain spotted fever in Arizona?

Rocky Mountain spotted fever (RMSF) is a tick-borne bacterial infection that can cause permanent disability...

Backer Badge Funded